Accused rapist Gary Zerola’s case is now in the hands of Suffolk Superior jury
Published Wed, 03 Jul 2024 03:40:41 GMT
International reinforcements arrive in Quebec as wildfires stabilize
Published Wed, 03 Jul 2024 03:40:41 GMT
Stock market today: Wall Street is mixed; Big Tech climbs
Published Wed, 03 Jul 2024 03:40:41 GMT
Biden in North Carolina to push clean energy agenda and promote order aiding military spouses
Published Wed, 03 Jul 2024 03:40:41 GMT
Federal prosecutors charge Texas businessman linked to Attorney General Ken Paxton’s impeachment
Published Wed, 03 Jul 2024 03:40:41 GMT
New York lawmakers consider bill to automatically seal old criminal records
Published Wed, 03 Jul 2024 03:40:41 GMT
Ukrainian Freedom Orchestra will tour with stops in Europe and Britain to support war effort
Published Wed, 03 Jul 2024 03:40:41 GMT
Young black bear wanders Washington D.C. neighborhood, sparking a frenzy before being captured
Published Wed, 03 Jul 2024 03:40:41 GMT
Trump faces unprecedented legal peril, but will it hurt his standing with Republican voters?
Published Wed, 03 Jul 2024 03:40:41 GMT
Cabins destroyed during ‘explosive growth’ of wildfire near Sambaa K’e, N.W.T.
Published Wed, 03 Jul 2024 03:40:41 GMT
Latest news
- RPM International, Acuity Brands rise; Cal-Maine, Helen of Troy fall, Wednesday, 10/4/2023
- Kenyan opposition lawmakers say the Haiti peacekeeping mission must be approved by parliament
- Tennis player apologizes for hitting a chair umpire with ball in Shanghai Masters qualifying
- Jannik Sinner wins China Open. Iga Swiatek advances to quarterfinals
- Pakistani army says 2 people were killed when a Taliban guard opened fire at a border crossing
- Meet this year’s MacArthur ‘genius grant’ recipients, including a hula master and the poet laureate
- A man charged with voter fraud in Florida blames rivalry between Trump and DeSantis supporters
- Rudy Giuliani: ‘I have never had an alcohol problem’
- Scalise and Jordan launch bids for House speaker after McCarthy ouster
- Moderna’s flu-Covid combo vaccine elicits ‘strong’ immune response in Phase 1/2 study, company says